A precision drug for prostate cancer may slow the disease’s spread
The drug olaparib could be used to treat men with certain genetic mutations and severe types of prostate cancer, a clinical trial finds.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
